Hemogenyx Pharmaceuticals PLC HOPHF:OTCPK

RT Quote | Exchange | USD
Last | 02/24/21 EST
0.11UNCH (UNCH)
52 week range
0.11 - 0.15

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.11
  • 52 Week High0.15
  • 52 Week High Date01/12/21
  • 52 Week Low0.11
  • 52 Week Low Date02/24/21
  • Market Cap40.58M
  • Shares Out433.64M
  • 10 Day Average Volume45,000
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Hemogenyx Pharmaceuticals PLC News

There is no recent news for this security.

Latest HOPHF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Hemogenyx Pharmaceuticals Plc, formerly Silver Falcon Plc, is a biotechnology company. The Company is focused on developing new treatments for blood diseases such as leukaemia, lymphoma and blood marrow failure. Its therapies are designed to provide new treatments in bone marrow/stem cell transplants, improving the success and safety of such treatments. Its products include Conditioning and Cell therapy product. Conditioning product is for CDX bi-specific antibodies...
Marc Feldmann
Chairman
Address
1st Fl Ofc 4, 50 Jermyn Street
London
SW1Y 6LX
United Kingdom